UNSPSC 51294204: Indeloxazine

This classification denotes an antidepressant agent with the molecular formula C14H17NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 834M09R1KM, chemically known as (r,s)-2-(7-indenyloxymethyl)morpholin but generally known as indeloxazine, which bears US NIH Compound Identifier 3704. European Medicines Agency schedules Indeloxazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08172MIG. The term INDELOXAZINE is an International Non-Proprietary Name.

UNSPSC 51294204 Indeloxazine, a Commodity code, encompasses pharmaceutical products and medical countermeasures that state and local health departments, emergency management agencies, and community health organizations procure to support public health and emergency response initiatives. The recent solicitation activity shows that jurisdictions are using this code to acquire naloxone (opioid reversal medication) and drug deactivation systems as part of community health and harm-reduction programming. State and local buyers under this code include county health departments and emergency preparedness offices operating at the community and regional level.

Seminole County, Florida, posted an IFB (Invitation for Bid) in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The bid required electronic submission through the county's e-Procurement Portal, with a response deadline of July 26, 2023, at 2:00 pm, and included standard compliance requirements such as drug-free workplace certification, E-Verify authorization, and workers' compensation and commercial general liability insurance. The contract structure offered an initial two-year term with an option for a one-year renewal and potentially drew funding through FEMA, introducing additional federal compliance obligations including adherence to the Clean Air Act and Federal Water Pollution Control Act. The procurement did not specify explicit set-aside designations.